Abstract
Phenylmethylsulfonyl fluoride (PMSF) is a protease and esterase inhibitor that causes protection, or potentiation/“promotion,” of organophosphorus delayed neuropathy (OPIDN), depending on whether it is dosed before or after an inducer of delayed neuropathy, such as mipafox. The molecular target of the potentiation/promotion of OPIDN has not yet been identified. The kinetic data of phenyl valerate esterase inhibition by PMSF were obtained with membrane chicken brain fractions, the animal model and tissue in which neuropathy target esterase (NTE) was first described. Data were analyzed using a kinetic model with a multienzymatic system in which inhibition, simultaneous chemical hydrolysis of the inhibitor and “ongoing inhibition” (inhibition during the substrate reaction) were considered. Three main esterase components were discriminated: two sensitive enzymatic entities representing 44 and 41 %, with I 50 (20 min) of 35 and 198 μM at 37 °C, respectively, and a resistant fraction of 15 % of activity. The estimated constant of the chemical hydrolysis of PMSF was also calculated (kh = 0.28 min−1). Four esterase components were globally identified considering also previously data with paraoxon and mipafox: EPα (4–8 %), highly sensitive to paraoxon and mipafox, spontaneously reactivates after inhibition with paraoxon, and resistant to PMSF; EPβ (38–41 %), sensitive to paraoxon and PMSF, but practically resistant to mipafox, this esterase component has the kinetic characteristics expected for the PMSF potentiator target, even though paraoxon cannot be a potentiator in vivo due to high AChE inhibition; EPγ (NTE) (39–48 %), paraoxon-resistant and sensitive to the micromolar concentration of mipafox and PMSF; and EPδ (10 %), resistant to all the inhibitors assayed. This kinetic characterization study is needed for further isolation and molecular characterization studies, and these PMSF phenyl valerate esterase components will have to be considered in further studies of OPIDN promotion. A simple test for monitoring the four esterase components is proposed.
Similar content being viewed by others
Abbreviations
- AChE:
-
Acetylcholinesterase
- DMSO:
-
Dimethylsulfoxide
- EDTA:
-
Ethylenediaminetetraacetic acid
- NTE:
-
Neuropathy target esterase
- OECD:
-
Organization for economic cooperation and development
- OP:
-
Organophosphorus compounds
- PV:
-
Phenyl valerate
- PMSF:
-
Phenylmethylsulfonyl fluoride
- OPIDN:
-
Organophosphate-induced delayed neuropathy
References
Aldridge N (1993) Postscript to the symposium on organophosphorus compound induced delayed neuropathy. V Chem Biol Interact 87(1–3):463–466
Céspedes MV, Escudero MA, Barril J, Sogorb MA, Vicedo JL, Vilanova E (1997) Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter. Chem-Biol Interact 106:191–200
COT report (1999) Organophosphates. A report of the committee on toxicology of chemicals in food, consumer products and the environment. UK Department of Health, London
Estévez J, Vilanova E (2009) Model equations for the kinetics of covalent irreversible enzyme inhibition and spontaneous reactivation: esterases and organophosphorus compounds. Crit Rev Toxicol 39(5):427–448
Estevez J, Mangas I, Sogorb MA, Vilanova E (2013) Interactions of neuropathy inducers and promoters with soluble esterases. Chem Biol Interact doi:10.1016/j.cbi.2012.11.007
Estévez J, Barril J, Vilanova E (2010) Inhibition with spontaneous reactivation and the “ongoing inhibition” effect of esterases by biotinylated organophosphorus compounds: S9B as a model. Chem Biol Interact 187:397–402
Estévez J, Barril J, Vilanova E (2012) Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity. Arch Toxicol 86(5):767–777
Glynn P (2000) Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog Neurobiol 61(1):61–74 Review
Gupta RP, Abdel-Rahman A, Jensen KF, Abou-Donia MB (2000) Altered expression of neurofilament subunits in diisopropyl phosphorofluoridate-treated hen spinal cord and their presence in axonal aggregations. Brain Res 878(1–2):32–47
Jamal GA, Hansen S, Julu POO (2002) Low level exposures to organophosphorus esters may cause neurotoxicity. Toxicology 181–182:23–33
James GT (1978) Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal Biochem 86(2):574–579
Johnson MK (1969a) The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem J 114:711–717
Johnson MK (1969b) Delayed neurotoxic action of some organophosphorus compounds. Br Med Bull 25(3):231–235
Johnson MK (1974) The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J Neurochem 23:785–789
Johnson MK (1977) Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 37:113–115
Johnson MK, Lauwerys R (1969) Protection by some carbamates against the delayed neurotoxic effects of di-isopropyl phosphorofluoridate. Nature 222(5198):1066–1067
Johnson MK, Read DJ (1993) Prophylaxis against and promotion of organophosphate-induced delayed neuropathy by phenyl di-n-pentylphosphinate. Chem Biol Interact 87(1–3):449–455
Johnson MK, Vilanova E, Read DJ (1989) Biochemical clinical tests of the delayed neuropathic potential of some O-alkyl o-dichlorophenyl phosphoramidate analogues of methamidophos (O, S-dimethyl phosphorothioamidate). Toxicology 54:89–100
Johnson MK, Vilanova E, Read DJ (1991) Anomalous biochemical responses in test of the delayed neuropathic potential of methamidophos (O, S-dimethyl phosphoramidates.), its resolved isomers and of some higher O-alkyl homologues. Arch Toxicol 65:618–624
Kemp J, Wallace K (1990) Molecular determinants of the species-selective inhibition of brain acetylcholinesterase. Toxicol Appl Pharmacol 104:246–258
Lotti M (2002) Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Toxicology 181–182:245–248 Review
Lotti M, Caroldi S, Capodicasa E, Moretto A (1991) Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol Appl Pharmacol 108:234–241
Lotti M, Moretto A, Bertolazzi M, Peraica M, Fioroni F (1995) Organophosphate polyneuropathy and neuropathy target esterase: studies with methamidophos and its resolved optical isomers. Arch Toxicol 69(5):330–336
Mangas I, Vilanova E, Estévez J (2011) Kinetics of the inhibitory interaction of organophosphorus neuropathy inducers and non-inducers in soluble esterases in the avian nervous system. Toxicol Appl Pharmacol 256(3):360–368 Epub 2011 May 12
Mangas I, Estevez J, Vilanova E (2012a) NTE and non-NTE esterases in brain membrane: kinetic characterization with organophosphates. Toxicology 297(1–3):17–25
Mangas I, Vilanova E, Estévez J (2012b) Phenylmethylsulfonyl fluoride, a potentiator of neuropathy, alters the interaction of organophosphorus compounds with soluble brain esterases. Chem Res Toxicol 25(11):2393–2401
Middlemore-Risher ML, Buccafusco JJ, Terry AV (2010) Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats. Neurotoxicol Teratol 32:415–424
Milatovic D, Moretto A, Osman KA, Lotti M (1997) Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Chem Res Toxicol 10:1045–1048
Moretto A, Capodicasa E, Peraica M, Lotti M (1993) Phenylmethanesulfonyl fluoride delays the recovery from crush of peripheral nerves in hens. Chem Biol Interact 87(1–3):457–462
Moretto A, Bertolazzi M, Lotti M (1994) The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxicol Appl Pharmacol 129(1):133–137
Moretto A, Gardiman G, Panfilo S, Colle MA, Lock EA, Lotti M (2001) Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy. Toxicol Sci 62(2):274–279
Moretto A, Nicolli A, Lotti M (2007) The search of the target of promotion: phenylbenzoate esterase activities in hen peripheral nerve. Toxicol Appl Pharmacol 219(2–3):196–201
Moser M, Li Y, Vaupel K, Kretzschmar D, Kluge R, Glynn P, Buettner R (2004) Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol Cell Biol 24(4):1667–1679
Nomura DK, Casida JE (2011) Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brain. J Agric Food Chem 59(7):2808–2815
Nomura DK, Leung D, Chiang KP, Quistad GB, Cravatt BF, Casida JE (2005) A brain detoxifying enzyme for organophosphorus nerve poisons. Proc Natl Acad Sci USA 102(17):6195–6200
Nomura DK, Blankman JL, Simon GM, Fujioka K, Issa RS, Ward AM, Cravatt BF, Casida JE (2008) Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol 4:373–378
Osman KA, Moretto A, Lotti M (1996) Sulfonyl fluorides and the promotion of diisopropyl fluorophosphate neuropathy. Fundam Appl Toxicol 33(2):294–297
Pamies D, Reig JA, Vilanova E, Sogorb MA (2010) Expression of neuropathy target esterase in mouse embryonic stem cells during differentiation. Arch Toxicol 84(6):481–491
Parron T, Hernandez AT, Villanueva E (1996) Increased risk of suicide with exposure to pesticides in an intensive agricultural area: a 12 year retrospective study. Forensic Sci Int 79(1):53–63
Pope CN, Padilla S (1990) Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J Toxicol
Quistad GB, Casida JE (2004) Lysophospholipase inhibition by organophosphorus toxicants. Toxicol Appl Pharmacol 196(3):319–326
Quistad GB, Barlow C, Winrow CJ, Sparks SE, Casida JE (2003) Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc Natl Acad Sci USA 100(13):7983–7987
Read DJ, Li Y, Chao MV, Cavanagh JB, Glynn P (2009) Neuropathy target esterase is required for adult vertebrate axon maintenance. J Neurosci 29(37):11594–11600
Vicedo JL, Carrera V, Barril J, Vilanova E (1993) Properties of partly preinhibited hen brain neuropathy target esterase. Chem Biol Interact 87(1–3):417–423
Vilanova E, Johnson MK, Vicedo JL (1987) The interaction of some unsubstituted phosphoramidates analogues of methamidophos (O, S-dimethyl phosphorothioamidate) with acetylcholinesterase and neuropathy target esterase of hen brain. Pesticide Biochem Physiol 28:224–238
Winrow CJ, Hemming ML, Allen DM, Quistad GB, Casida JE, Barlow C (2003) Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat Genet 33(4):477–485
Xie K, Gupta RP, Abou-Donia MB (2002) Protein levels of neurofilament subunits in the hen central nervous system following prevention and potentiation of diisopropyl phosphorofluoridate (DFP)-induced delayed neurotoxicity. Biochem Pharmacol 63(1):11–19
Zaccheo O, Dinsdale D, Meacock PA, Glynn P (2004) Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Biol Chem 279(23):24024–24033
Conflict of interest
The authors declare that there are no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mangas, I., Vilanova, E. & Estévez, J. Kinetic interactions of a neuropathy potentiator (phenylmethylsulfonyl fluoride) with the neuropathy target esterase and other membrane bound esterases. Arch Toxicol 88, 355–366 (2014). https://doi.org/10.1007/s00204-013-1135-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-013-1135-0